1.Some remarks on infrastructures, equipments, personnels and professionals of commune hospitals - Thuy Nguyên District - Hai Phong
Journal of Vietnamese Medicine 2004;304(11):101-109
The real situation of infrastructures, equipments, personals and professionals of 34 commune medical stations - Thuy Nguyen district - Hai Phong in 2002. 64.71% houses with a flat roof, 35.29% grade - 3 houses, 12.6% not medicine plant. 38.2% commune medical stations have equipment with capital speciality. 70.5% females, 91.14% staffs, 8.8% contracts. 100% commune medical stations have doctor, 329 hamlets have health of hamlet. Commune medical stations training office of management are 15/34, commune medical stations training office of health care education are 24/34, commune medical stations training office of HIV/AIDS are 15/34, vaccinate achieved 100%
Hospitals
;
Medical staffs
;
Epidemiology
2.Management of Male Infertility with Coexisting Sexual Dysfunction: A Consensus Statement and Clinical Recommendations from the Asia-Pacific Society of Sexual Medicine (APSSM) and the Asian Society of Men’s Health and Aging (ASMHA)
Eric CHUNG ; Jiang HUI ; Zhong Cheng XIN ; Sae Woong KIM ; Du Geon MOON ; Yiming YUAN ; Koichi NAGAO ; Lukman HAKIM ; Hong-Chiang CHANG ; Siu King MAK ; Gede Wirya Kusuma DUARSA ; Yutian DAI ; Bing YAO ; Hwancheol SON ; William HUANG ; Haocheng LIN ; Quang NGUYEN ; Dung Ba Tien MAI ; Kwangsung PARK ; Joe LEE ; Kavirach TANTIWONGSE ; Yoshikazu SATO ; Bang-Ping JIANN ; Christopher HO ; Hyun Jun PARK
The World Journal of Men's Health 2024;42(3):471-486
Male infertility (MI) and male sexual dysfunction (MSD) can often coexist together due to various interplay factors such as psychosexual, sociocultural and relationship dynamics. The presence of each form of MSD can adversely impact male reproduction and treatment strategies will need to be individualized based on patients’ factors, local expertise, and geographical socioeconomic status. The Asia Pacific Society of Sexual Medicine (APSSM) and the Asian Society of Men’s Health and Aging (ASMHA) aim to provide a consensus statement and practical set of clinical recommendations based on current evidence to guide clinicians in the management of MI and MSD within the Asia-Pacific (AP) region. A comprehensive, narrative review of the literature was performed to identify the various forms of MSD and their association with MI. MEDLINE and EMBASE databases were searched for the following English language articles under the following terms: “low libido”, “erectile dysfunction”, “ejaculatory dysfunction”, “premature ejaculation”, “retrograde ejaculation”, “delayed ejaculation”, “anejaculation”, and “orgasmic dysfunction” between January 2001 to June 2022 with emphasis on published guidelines endorsed by various organizations. This APSSM consensus committee panel evaluated and provided evidence-based recommendations on MI and clinically relevant MSD areas using a modified Delphi method by the panel and specific emphasis on locoregional socioeconomic-cultural issues relevant to the AP region. While variations exist in treatment strategies for managing MI and MSD due to geographical expertise, locoregional resources, and sociocultural factors, the panel agreed that comprehensive fertility evaluation with a multidisciplinary management approach to each MSD domain is recommended. It is important to address individual MI issues with an emphasis on improving spermatogenesis and facilitating reproductive avenues while at the same time, managing various MSD conditions with evidence-based treatments. All therapeutic options should be discussed and implemented based on the patient’s individual needs, beliefs and preferences while incorporating locoregional expertise and available resources.
3.Artificial Intelligence in Andrology: From Semen Analysis to Image Diagnostics
Ramy Abou GHAYDA ; Rossella CANNARELLA ; Aldo E. CALOGERO ; Rupin SHAH ; Amarnath RAMBHATLA ; Wael ZOHDY ; Parviz KAVOUSSI ; Tomer AVIDOR-REISS ; Florence BOITRELLE ; Taymour MOSTAFA ; Ramadan SALEH ; Tuncay TOPRAK ; Ponco BIROWO ; Gianmaria SALVIO ; Gokhan CALIK ; Shinnosuke KURODA ; Raneen Sawaid KAIYAL ; Imad ZIOUZIOU ; Andrea CRAFA ; Nguyen Ho Vinh PHUOC ; Giorgio I. RUSSO ; Damayanthi DURAIRAJANAYAGAM ; Manaf AL-HASHIMI ; Taha Abo-Almagd Abdel-Meguid HAMODA ; Germar-Michael PINGGERA ; Ricky ADRIANSJAH ; Israel Maldonado ROSAS ; Mohamed ARAFA ; Eric CHUNG ; Widi ATMOKO ; Lucia ROCCO ; Haocheng LIN ; Eric HUYGHE ; Priyank KOTHARI ; Jesus Fernando Solorzano VAZQUEZ ; Fotios DIMITRIADIS ; Nicolas GARRIDO ; Sheryl HOMA ; Marco FALCONE ; Marjan SABBAGHIAN ; Hussein KANDIL ; Edmund KO ; Marlon MARTINEZ ; Quang NGUYEN ; Ahmed M. HARRAZ ; Ege Can SEREFOGLU ; Vilvapathy Senguttuvan KARTHIKEYAN ; Dung Mai Ba TIEN ; Sunil JINDAL ; Sava MICIC ; Marina BELLAVIA ; Hamed ALALI ; Nazim GHERABI ; Sheena LEWIS ; Hyun Jun PARK ; Mara SIMOPOULOU ; Hassan SALLAM ; Liliana RAMIREZ ; Giovanni COLPI ; Ashok AGARWAL ;
The World Journal of Men's Health 2024;42(1):39-61
Artificial intelligence (AI) in medicine has gained a lot of momentum in the last decades and has been applied to various fields of medicine. Advances in computer science, medical informatics, robotics, and the need for personalized medicine have facilitated the role of AI in modern healthcare. Similarly, as in other fields, AI applications, such as machine learning, artificial neural networks, and deep learning, have shown great potential in andrology and reproductive medicine. AI-based tools are poised to become valuable assets with abilities to support and aid in diagnosing and treating male infertility, and in improving the accuracy of patient care. These automated, AI-based predictions may offer consistency and efficiency in terms of time and cost in infertility research and clinical management. In andrology and reproductive medicine, AI has been used for objective sperm, oocyte, and embryo selection, prediction of surgical outcomes, cost-effective assessment, development of robotic surgery, and clinical decision-making systems. In the future, better integration and implementation of AI into medicine will undoubtedly lead to pioneering evidence-based breakthroughs and the reshaping of andrology and reproductive medicine.